Skip to main content
Top
Published in: Annals of Surgical Oncology 5/2014

01-05-2014 | Healthcare Policy and Outcomes

Big Data and Clinical Research in Oncology: The Good, the Bad, the Challenges, and the Opportunities

Author: Christopher M. Pezzi, MD

Published in: Annals of Surgical Oncology | Issue 5/2014

Login to get access

Excerpt

National cancer registries provide an ever-growing volume of data and increasing access to that data for the purpose of clinical research in oncology. In the United States, three national cancer-specific registries have been developed to collect data on cancer patients, their cancers, how they are treated, and their outcomes. Beginning with the passage of the National Cancer Act of 1971 and funded since 1973, the National Cancer Institute (NCI)’s Surveillance Epidemiology and End Results (SEER) program is a population-based registry from 20 U.S. geographic areas, covering ~28 % of the U.S. population.1 In 1989, the American College of Surgeons (ACoS) Commission on Cancer (CoC) started a joint program with the American Cancer Society: the National Cancer Data Base (NCDB). Approximately 70 % of all new cancer cases diagnosed in the United States each year are currently captured by the NCDB, which contains the records of ~29 million patients from ~1,500 institutions (making the NCDB a hospital-based, not population-based, registry).2 Finally, the National Program of Cancer Registries (NPCR) was established in 1992 and is administered by the U.S. Centers for Disease Control and Prevention (CDC). NPCR supports cancer registries in 45 states, representing 96 % of the U.S. population.3 The data entered into each of these three national cancer registries are not collected completely independently of the others. The processes, system, and rules that govern the data collection for all three registries significantly overlap, as do the professionals (cancer registrars/CTRs) who actually collect and enter the data. The North American Association of Central Cancer Registries Inc. (NAACR), established in 1987, is a collaborative umbrella organization that develops and promotes uniform data standards for the cancer registries. All central cancer registries in the United States (and Canada) are members of NAACR,4 although each registry may require a different subset of data elements to be reported. …
Literature
5.
Metadata
Title
Big Data and Clinical Research in Oncology: The Good, the Bad, the Challenges, and the Opportunities
Author
Christopher M. Pezzi, MD
Publication date
01-05-2014
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 5/2014
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-3519-7

Other articles of this Issue 5/2014

Annals of Surgical Oncology 5/2014 Go to the issue